Atrial Fibrillation (Oxcard Library)

Erscheinungsjahr 2015
ISBN: 978-0-19-968631-5
Verlag: Oxford University Press

Buch, Englisch, 168 Seiten, Print PDF, Format (B × H): 130 mm x 195 mm, Gewicht: 211 g

Atrial Fibrillation is becoming a twenty-first century epidemic. It remains the most common form of sustained arrhythmia with significant mortality, morbidity and cost to the health care system. It is the most common cause of hospital admissions among all arrhythmias. Its prevalence increases with the aging population and is often associated with many other cardiac and noncardiac conditions, most notably congestive heart failure, hypertension, diabetes, and coronary artery disease. Although significant progress in understanding the epidemiology, natural history and mechanism has been made, the antiarrhythmic therapy in patients with Atrial Fibrillation is less satisfactory.

Management of Atrial Fibrillation: A Practical Approach is the perfect pocket guide for those who care for patients afflicted by Atrial Fibrillation. From the history of the condition and the subsets of patients, to therapeutic and preventive procedures, Management of Atrial Fibrillation comprehensively covers all aspects in managing this increasingly prevalent disorder. Written by leading authorities in the field with vast experience in practical medicine, the book creates a clinically orientated, evidence based "fast fact" type resource for cardiologists, trainees and related healthcare professionals.

Autoren/Hrsg.

Shenasa, Mohammad

Camm, A. John

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Innere Medizin
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Kardiologie, Angiologie, Phlebologie

Inhaltsverzeichnis

- 1: Christopher McLeod and Bernard J. Gersh: The Epidemiology of Atrial Fibrillation

- 2: James A. Reiffel: What should be done when Atrial Fibrillation first presents

- 3: Bart A. Mulder and Isabelle C. Van Gelder: Workup of Patients with Atrial Fibrillation

- 4: Mohammad Shenasa and Shahrzad Rouhani: Atrial Fibrillation in Different Clinical Subsets

- 5: Irina Savelieva and A. John Camm: Management of Atrial Fibrillation, Antiarrhythmic Selection, Etiology Based

- 6: Christos Dresios and Gregory Y.H. Lip: Anticoagulation Selection and Stroke Prevention

- 7: L. Brent Mitchell: When to Refer Patients for Non Pharmacological Therapies (AF ablation, Atrioventricular nodal ablation, Pacer/ICD and Left Atrial Appendage closure)

- 8: Cevher Ozcan and Anne Curtis: Summary Guidelines for Management of Atrial Fibrillation

Über Autor(innen)

Dr. Mohammad Shenasa qualified in 1975. He trained at the University of Pennsylvania, Philadelphia, Guy's Hospital University of London, and Mount Sinai Medical Center-University of Wisconsin, Milwuakee. Dr Shenasa then took academic positions at the University of Montreal, Canada and in 1989 he became professor of medicine and director of clinical cardiac electrophysiology at the University of Pittsburg, Pennsylvania. He spent two years as a visiting professor at the University of Munster, Germany. He is currently an attending physician at the O'Connor Hospital department of cardiovascular services and Heart & Rhythm Medical Group in San Jose, CA. Dr. Shenasa published many research papers and edited several books relating to cardiac arrhythmias and its management.

Professor John Camm qualified in 1971. He worked at Guy's Hospital before working at St. Bartholomew's Hospital, London. In 1986 he moved to St. George's Hospital Medical School in London as Professor of Clinical Cardiology (British Heart Foundation). Professor Camm was elected the Chairman of Medicine in October 1990, a post rotated from in 1995. He is now the Chairman of the Division of Cardiac and Vascular Sciences at St. George's University of London. His major speciality is cardiac arrhythmias but he is also much involved in clinical cardiac electrophysiology, cardiac pacemakers, risk stratification in post myocardial infarction, heart failure and cardiomyopathy patients. He has a major interest in cardiovascular safety of cardiac and non-cardiac drugs. John has given over 1500 lectures to national and international audiences, written more than 1000 peer review papers and over 250 detailed reviews. He has authored and edited numerous books.